Word

ANELLOVECTOR

Status

Pending

Status Code

748

Status Date

Friday, March 29, 2024

Serial Number

98118232

Mark Type

4000

Filing Date

Friday, August 4, 2023

Published for Opposition

Tuesday, January 2, 2024

Trademark Owner History

Ring Therapeutics, Inc. - Owner At Publication

Classifications

5 Encapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy

Trademark Events

Mar 29, 2024

Statement Of Use Processing Complete

Mar 7, 2024

Use Amendment Filed

Mar 29, 2024

Case Assigned To Intent To Use Paralegal

Mar 7, 2024

Teas Statement Of Use Received

Feb 27, 2024

Noa E-Mailed - Sou Required From Applicant

Jan 2, 2024

Official Gazette Publication Confirmation E-Mailed

Jan 2, 2024

Published For Opposition

Dec 26, 2023

Teas Change Of Correspondence Received

Dec 26, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 26, 2023

Teas Change Of Owner Address Received

Dec 13, 2023

Notification Of Notice Of Publication E-Mailed

Nov 29, 2023

Approved For Pub - Principal Register

Nov 28, 2023

Assigned To Examiner

Aug 11, 2023

New Application Office Supplied Data Entered

Aug 8, 2023

New Application Entered